Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.71 |
| ▸ | HPGD | P15428 | 6/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7069498 | 0.99 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL7073745 | 0.99 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL7071614 | 0.99 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL97245 | 0.99 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL7044150 | 0.99 | ALDH1A1 (0.69) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL7071108 | 0.96 | ALDH1A1 (0.73) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL95135 | 0.92 | ALDH1A1 (0.61) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL7073326 | 0.90 | ALDH1A1 (0.77) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL28118940 | 0.82 | ALDH1A1 (0.49) | ALDH1A1KDM4EHPGDGAAMAPT | |
| SCHEMBL11399430 | 0.79 | MAPT (0.55) | ALDH1A1KDM4EHPGDGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020081726-A1 | METHODS OF TREATING MENOPAUSAL SYMPTOMS USING LOW DOSE PROGESTERONE | STADLER SARAH SHEEHAN (US) | 2020-04-23 | — | — | WO | claimed |
| EP-1620060-B1 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS | GEN HOSPITAL CORP (US) | 2010-03-24 | — | — | EP | claimed |
| EP-1620060-A4 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS | GEN HOSPITAL CORP (US) | 2007-11-28 | — | — | EP | claimed |
| US-20070196433-A1 | Methods and devices for the sustained release of multiple drugs | THE MASSACHUSETTS GENERAL HOSPITAL CORPORATION | 2007-08-23 | — | — | US | claimed |
| EP-1620060-A2 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS | THE GENERAL HOSPITAL CORPORATION (US) | 2006-02-01 | — | — | EP | claimed |
| WO-2004096151-A2 | METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS | THE GENERAL HOSPITAL CORPORATION (US) | 2004-11-11 | — | — | WO | claimed |
| EP-2779996-B1 | DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS | UPM KYMMENE CORP (FI) | 2024-04-10 | — | — | EP | disclosed |
| US-11389537-B2 | Drug delivery system for sustained delivery of bioactive agents | UPM-KYMMENE CORPORATION (FI) | 2022-07-19 | — | — | US | disclosed |
| US-20210386757-A1 | Methods of Treating Menopausal Symptoms Using Low Dose Progesterone | STADLER SARAH S (US) | 2021-12-16 | — | — | US | disclosed |
| EP-3395332-A1 | HORMONE SOFTGEL CAPSULES AND A PROCESS FOR THE PREPARATION THEREOF | Chemo Research, S.L. (ES) | 2018-10-31 | — | — | EP | disclosed |
| EP-2456421-B1 | MULTI-LAYERED GRADIENT VAGINAL RING | THE POPULATION COUNCIL INC (US) | 2017-04-05 | — | — | EP | disclosed |
| US-20140322327-A1 | DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS | UPM-KYMMENE CORPORATION (FI) | 2014-10-30 | — | — | US | disclosed |
| EP-2779996-A1 | DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS | UPM-Kymmene Corporation (FI) | 2014-09-24 | — | — | EP | disclosed |
| US-5696133-A | ADMINISTERING COMPOUND WHICH MODULATES ACTIVITY OF PROGESTERONE RECEPTOR | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-09 | — | — | US | disclosed |
| US-5693647-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5693646-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5688808-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| US-5688810-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0800519-A1 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS, INC. (US) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996019458-A2 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1996-06-27 | — | — | WO | disclosed |